| Year |
Citation |
Score |
| 2021 |
Balan S, Iwayama Y, Ohnishi T, Fukuda M, Shirai A, Yamada A, Weirich S, Schuhmacher MK, Dileep KV, Endo T, Hisano Y, Kotoshiba K, Toyota T, Otowa T, Kuwabara H, et al. A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular Psychiatry. PMID 34262135 DOI: 10.1038/s41380-021-01199-7 |
0.547 |
|
| 2021 |
Ohnishi T, Kiyama Y, Arima-Yoshida F, Kadota M, Ichikawa T, Yamada K, Watanabe A, Ohba H, Tanaka K, Nakaya A, Horiuchi Y, Iwayama Y, Toyoshima M, Ogawa I, Shimamoto-Mitsuyama C, et al. Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. Embo Molecular Medicine. e12574. PMID 33656268 DOI: 10.15252/emmm.202012574 |
0.622 |
|
| 2021 |
Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Toyoshima M, Hara T, Hisano Y, Miyasaka Y, Toyota T, Shimamoto-Mitsuyama C, Maekawa M, Numata S, Ohmori T, Shimogori T, et al. Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia Bulletin. PMID 33595068 DOI: 10.1093/schbul/sbab007 |
0.594 |
|
| 2020 |
Wada Y, Maekawa M, Ohnishi T, Balan S, Matsuoka S, Iwamoto K, Iwayama Y, Ohba H, Watanabe A, Hisano Y, Nozaki Y, Toyota T, Shimogori T, Itokawa M, Kobayashi T, et al. Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. Ebiomedicine. 103130. PMID 33279456 DOI: 10.1016/j.ebiom.2020.103130 |
0.539 |
|
| 2020 |
Maekawa M, Ohnishi T, Toyoshima M, Shimamoto-Mitsuyama C, Hamazaki K, Balan S, Wada Y, Esaki K, Takagai S, Tsuchiya KJ, Nakamura K, Iwata Y, Nara T, Iwayama Y, Toyota T, et al. A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder. Brain Communications. 2: fcaa145. PMID 33225276 DOI: 10.1093/braincomms/fcaa145 |
0.52 |
|
| 2020 |
Horiuchi Y, Ichikawa T, Ohnishi T, Iwayama Y, Toriumi K, Miyashita M, Nohara I, Obata N, Toyota T, Yoshikawa T, Itokawa M, Arai M. locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder. Human Genome Variation. 7: 31. PMID 33082982 DOI: 10.1038/s41439-020-00117-7 |
0.587 |
|
| 2020 |
Shimamoto-Mitsuyama C, Nakaya A, Esaki K, Balan S, Iwayama Y, Ohnishi T, Maekawa M, Toyota T, Dean B, Yoshikawa T. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cerebral Cortex (New York, N.Y. : 1991). PMID 32924060 DOI: 10.1093/cercor/bhaa236 |
0.598 |
|
| 2020 |
Usui N, Iwata K, Miyachi T, Takagai S, Wakusawa K, Nara T, Tsuchiya KJ, Matsumoto K, Kurita D, Kameno Y, Wakuda T, Takebayashi K, Iwata Y, Fujioka T, Hirai T, ... ... Ohnishi T, et al. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction. Ebiomedicine. 58: 102917. PMID 32739868 DOI: 10.1016/j.ebiom.2020.102917 |
0.469 |
|
| 2020 |
Qu Y, Zhang K, Pu Y, Chang L, Wang S, Tan Y, Wang X, Zhang J, Ohnishi T, Yoshikawa T, Hashimoto K. Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. Journal of Affective Disorders. 272: 66-76. PMID 32379622 DOI: 10.1016/j.jad.2020.03.095 |
0.471 |
|
| 2020 |
Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Shimogori T, Hayashi T, Kikkawa Y, Yoshikawa T. Genetic Deciphering of Prepulse Inhibition Reveals the Putative Role of an Atypical Cadherin in Schizophrenia Pathogenesis Biological Psychiatry. 87: S398. DOI: 10.1016/j.biopsych.2020.02.1017 |
0.362 |
|
| 2019 |
Ide M, Ohnishi T, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C, Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y, Hara T, et al. Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology. Embo Molecular Medicine. e10695. PMID 31657521 DOI: 10.15252/Emmm.201910695 |
0.574 |
|
| 2019 |
Toyoshima M, Jiang X, Ogawa T, Ohnishi T, Yoshihara S, Balan S, Yoshikawa T, Hirokawa N. Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis. Life Science Alliance. 2. PMID 31591136 DOI: 10.26508/lsa.201900478 |
0.529 |
|
| 2019 |
Ohnishi T, Balan S, Toyoshima M, Maekawa M, Ohba H, Watanabe A, Iwayama Y, Fujita Y, Tan Y, Hisano Y, Shimamoto-Mitsuyama C, Nozaki Y, Esaki K, Nagaoka A, Matsumoto J, et al. Investigation of betaine as a novel psychotherapeutic for schizophrenia. Ebiomedicine. PMID 31255657 DOI: 10.1016/j.ebiom.2019.05.062 |
0.57 |
|
| 2019 |
Shimamoto-Mitsuyama C, Ohnishi T, Balan S, Ohba H, Watanabe A, Maekawa M, Hisano Y, Iwayama Y, Owada Y, Yoshikawa T. Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice. Schizophrenia Research. PMID 30765249 DOI: 10.1016/j.schres.2019.02.002 |
0.61 |
|
| 2018 |
Nakamura T, Nakajima K, Ohnishi T, Yoshikawa T, Nakanishi M, Takumi T, Tsuboi T, Kato T. Quantitative evaluation of incomplete preweaning lethality in mice by using the CRISPR/Cas9 system. Scientific Reports. 8: 16025. PMID 30375401 DOI: 10.1038/s41598-018-34270-5 |
0.502 |
|
| 2018 |
Maekawa M, Ohnishi T, Balan S, Hisano Y, Nozaki Y, Ohba H, Toyoshima M, Shimamoto C, Tabata C, Wada Y, Yoshikawa T. Thiosulfate promotes hair growth in mouse model. Bioscience, Biotechnology, and Biochemistry. 1-9. PMID 30200826 DOI: 10.1080/09168451.2018.1518705 |
0.397 |
|
| 2017 |
Maekawa M, Watanabe A, Iwayama Y, Kimura T, Hamazaki K, Balan S, Ohba H, Hisano Y, Nozaki Y, Ohnishi T, Toyoshima M, Shimamoto C, Iwamoto K, Bundo M, Osumi N, et al. Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes. Translational Psychiatry. 7: e1229. PMID 28872641 DOI: 10.1038/Tp.2017.182 |
0.392 |
|
| 2016 |
Ohnishi T, Miura I, Ohba H, Shimamoto C, Iwayama Y, Wakana S, Yoshikawa T. A spontaneous and novel Pax3 mutant mouse that models Waardenburg syndrome and neural tube defects. Gene. PMID 28043919 DOI: 10.1016/j.gene.2016.12.037 |
0.462 |
|
| 2016 |
Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, et al. Erratum: Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism. Scientific Reports. 6: 20268. PMID 26822806 DOI: 10.1038/Srep20268 |
0.469 |
|
| 2015 |
Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, et al. Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism. Scientific Reports. 5: 16239. PMID 26548558 DOI: 10.1038/Srep16239 |
0.552 |
|
| 2015 |
Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, et al. Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies. Human Molecular Genetics. 24: 2409. PMID 25655139 DOI: 10.1093/hmg/ddv011 |
0.624 |
|
| 2015 |
Maekawa M, Yamada K, Toyoshima M, Ohnishi T, Iwayama Y, Shimamoto C, Toyota T, Nozaki Y, Balan S, Matsuzaki H, Iwata Y, Suzuki K, Miyashita M, Kikuchi M, Kato M, et al. Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses. Biological Psychiatry. 78: 116-25. PMID 25444170 DOI: 10.1016/J.Biopsych.2014.07.025 |
0.544 |
|
| 2015 |
Balan S, Iwayama Y, Yamada K, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Ide M, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T, Maekawa M. Sequencing and expression analyses of the synaptic lipid raft adapter gene PAG1 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 477-85. PMID 25005592 DOI: 10.1007/s00702-014-1269-0 |
0.592 |
|
| 2014 |
Balan S, Iwayama Y, Maekawa M, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Esaki K, Yamada K, Iwata Y, Suzuki K, Ide M, Ota M, Fukuchi S, Tsujii M, et al. Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects. Molecular Autism. 5: 49. PMID 25400900 DOI: 10.1186/2040-2392-5-49 |
0.553 |
|
| 2014 |
Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, et al. Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies. Human Molecular Genetics. 23: 6495-511. PMID 25027319 DOI: 10.1093/hmg/ddu369 |
0.659 |
|
| 2014 |
Ohnishi T, Murata T, Watanabe A, Hida A, Ohba H, Iwayama Y, Mishima K, Gondo Y, Yoshikawa T. Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis. The Journal of Biological Chemistry. 289: 10785-96. PMID 24554717 DOI: 10.1074/Jbc.M113.536706 |
0.522 |
|
| 2013 |
Balan S, Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Yoshikawa T. Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies. Plos One. 8: e70302. PMID 23936182 DOI: 10.1371/journal.pone.0070302 |
0.612 |
|
| 2013 |
Balan S, Yamada K, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Ujike H, Inada T, Kunugi H, Ozaki N, Iwata N, et al. Lack of association of EGR2 variants with bipolar disorder in Japanese population. Gene. 526: 246-50. PMID 23747400 DOI: 10.1016/j.gene.2013.05.055 |
0.563 |
|
| 2013 |
Takata A, Iwayama Y, Fukuo Y, Ikeda M, Okochi T, Maekawa M, Toyota T, Yamada K, Hattori E, Ohnishi T, Toyoshima M, Ujike H, Inada T, Kunugi H, Ozaki N, et al. A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biological Psychiatry. 73: 532-9. PMID 23237318 DOI: 10.1016/j.biopsych.2012.10.024 |
0.568 |
|
| 2013 |
Ohnishi T, Tanizawa Y, Watanabe A, Nakamura T, Ohba H, Hirata H, Kaneda C, Iwayama Y, Arimoto T, Watanabe K, Mori I, Yoshikawa T. Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes. Journal of Neurochemistry. 124: 685-94. PMID 23205734 DOI: 10.1111/Jnc.12112 |
0.541 |
|
| 2012 |
Yamada K, Iwayama Y, Toyota T, Ohnishi T, Ohba H, Maekawa M, Yoshikawa T. Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population. Human Genetics. 131: 443-51. PMID 21927946 DOI: 10.1007/s00439-011-1089-3 |
0.617 |
|
| 2011 |
Ohnishi T, Yamada K, Watanabe A, Ohba H, Sakaguchi T, Honma Y, Iwayama Y, Toyota T, Maekawa M, Watanabe K, Detera-Wadleigh SD, Wakana S, Yoshikawa T. Ablation of Mrds1/Ofcc1 induces hyper-γ-glutamyl transpeptidasemia without abnormal head development and schizophrenia-relevant behaviors in mice. Plos One. 6: e29499. PMID 22242126 DOI: 10.1371/journal.pone.0029499 |
0.613 |
|
| 2011 |
Yamada K, Iwayama Y, Hattori E, Iwamoto K, Toyota T, Ohnishi T, Ohba H, Maekawa M, Kato T, Yoshikawa T. Genome-wide association study of schizophrenia in Japanese population. Plos One. 6: e20468. PMID 21674006 DOI: 10.1371/journal.pone.0020468 |
0.605 |
|
| 2011 |
Fujita S, Ohnishi T, Okuda S, Kobayashi R, Fukuno S, Furuta D, Kikuchi T, Yoshikawa T, Fujita N. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2. Journal of Molecular Modeling. 17: 2559-67. PMID 21213002 DOI: 10.1007/s00894-010-0937-8 |
0.421 |
|
| 2010 |
Yoshikawa T, Maekawa M, Ohnishi T, Hashimoto K, Watanabe A. [Analysis of mouse strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 30: 197-200. PMID 21226315 |
0.607 |
|
| 2010 |
Maekawa M, Ohnishi T, Hashimoto K, Watanabe A, Iwayama Y, Ohba H, Hattori E, Yamada K, Yoshikawa T. Analysis of strain-dependent prepulse inhibition points to a role for Shmt1 (SHMT1) in mice and in schizophrenia. Journal of Neurochemistry. 115: 1374-85. PMID 20977478 DOI: 10.1111/j.1471-4159.2010.07039.x |
0.642 |
|
| 2010 |
Maekawa M, Iwayama Y, Watanabe A, Nozaki Y, Ohnishi T, Ohba H, Toyoshima M, Hamazaki K, Osumi N, Aruga J, Yoshikawa T. Excessive ingestion of long-chain polyunsaturated fatty acids during developmental stage causes strain- and sex-dependent eye abnormalities in mice. Biochemical and Biophysical Research Communications. 402: 431-7. PMID 20951676 DOI: 10.1016/J.Bbrc.2010.10.051 |
0.431 |
|
| 2010 |
Arai M, Yuzawa H, Nohara I, Ohnishi T, Obata N, Iwayama Y, Haga S, Toyota T, Ujike H, Arai M, Ichikawa T, Nishida A, Tanaka Y, Furukawa A, Aikawa Y, et al. Enhanced carbonyl stress in a subpopulation of schizophrenia. Archives of General Psychiatry. 67: 589-97. PMID 20530008 DOI: 10.1001/archgenpsychiatry.2010.62 |
0.518 |
|
| 2010 |
Iwata Y, Yamada K, Iwayama Y, Anitha A, Thanseem I, Toyota T, Hattori E, Ohnishi T, Maekawa M, Nakamura K, Suzuki K, Matsuzaki H, Tsuchiya KJ, Suda S, Sugihara G, et al. Failure to confirm genetic association of the FXYD6 gene with schizophrenia: the Japanese population and meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 1221-7. PMID 20468077 DOI: 10.1002/ajmg.b.31095 |
0.624 |
|
| 2010 |
Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Maekawa M, Yoshikawa T. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2. Neuroscience Research. 67: 86-94. PMID 20153384 DOI: 10.1016/j.neures.2010.02.003 |
0.562 |
|
| 2010 |
Maekawa M, Iwayama Y, Arai R, Nakamura K, Ohnishi T, Toyota T, Tsujii M, Okazaki Y, Osumi N, Owada Y, Mori N, Yoshikawa T. Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects. Journal of Human Genetics. 55: 127-30. PMID 20057506 DOI: 10.1038/Jhg.2009.133 |
0.62 |
|
| 2010 |
Iwayama Y, Hattori E, Maekawa M, Yamada K, Toyota T, Ohnishi T, Iwata Y, Tsuchiya KJ, Sugihara G, Kikuchi M, Hashimoto K, Iyo M, Inada T, Kunugi H, Ozaki N, et al. Association analyses between brain-expressed Fatty-Acid Binding Protein (FABP) genes and schizophrenia and bipolar disorder American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 153: 484-493. PMID 19554614 DOI: 10.1002/ajmg.b.31004 |
0.657 |
|
| 2009 |
Maekawa M, Iwayama Y, Nakamura K, Sato M, Toyota T, Ohnishi T, Yamada K, Miyachi T, Tsujii M, Hattori E, Maekawa N, Osumi N, Mori N, Yoshikawa T. A novel missense mutation (Leu46Val) of PAX6 found in an autistic patient. Neuroscience Letters. 462: 267-71. PMID 19607881 DOI: 10.1016/J.Neulet.2009.07.021 |
0.466 |
|
| 2009 |
Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Iwata Y, Tsuchiya KJ, Sugihara G, Kikuchi M, Okazaki Y, Yoshikawa T. Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 150: 508-514. PMID 18767121 DOI: 10.1002/ajmg.b.30847 |
0.603 |
|
| 2007 |
Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, Matsumata M, Ishitsuka Y, Nakaya A, Maekawa M, Ohnishi T, Arai R, Sakurai K, Yamada K, Kondo H, Hashimoto K, et al. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. Plos Biology. 5: e297. PMID 18001149 DOI: 10.1371/Journal.Pbio.0050297 |
0.616 |
|
| 2007 |
Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Aruga J, Minabe Y, Tonegawa S, Yoshikawa T. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 104: 2815-20. PMID 17360599 DOI: 10.1073/pnas.0610765104 |
0.643 |
|
| 2007 |
Arai R, Ito K, Ohnishi T, Ohba H, Akasaka R, Bessho Y, Hanawa-Suetsugu K, Yoshikawa T, Shirouzu M, Yokoyama S. Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures. Proteins. 67: 732-42. PMID 17340635 DOI: 10.1002/prot.21299 |
0.509 |
|
| 2007 |
Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, Hattori E, Inada T, Kunugi H, Tatsumi M, Ozaki N, Iwata N, Sakamoto K, Iijima Y, Iwata Y, Tsuchiya KJ, et al. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription Neuropsychopharmacology. 32: 1727-1737. PMID 17251911 DOI: 10.1038/Sj.Npp.1301307 |
0.561 |
|
| 2007 |
Nakatani N, Ohnishi T, Iwamoto K, Watanabe A, Iwayama Y, Yamashita S, Ishitsuka Y, Moriyama K, Nakajima M, Tatebayashi Y, Akiyama H, Higuchi T, Kato T, Yoshikawa T. Expression analysis of actin-related genes as an underlying mechanism for mood disorders. Biochemical and Biophysical Research Communications. 352: 780-6. PMID 17141188 DOI: 10.1016/j.bbrc.2006.11.101 |
0.536 |
|
| 2007 |
Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. The Journal of Biological Chemistry. 282: 637-46. PMID 17068342 DOI: 10.1074/Jbc.M604474200 |
0.534 |
|
| 2006 |
Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, Dedova I, Toyota T, Asada T, Takashima A, Yoshikawa T. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. Journal of Neurochemistry. 99: 277-87. PMID 16987250 DOI: 10.1111/j.1471-4159.2006.04033.x |
0.548 |
|
| 2006 |
Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I, Kato T, Osumi N, Higuchi T, Niwa S, Yoshikawa T. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation Human Molecular Genetics. 15: 1949-1962. PMID 16687443 DOI: 10.1093/Hmg/Ddl118 |
0.587 |
|
| 2006 |
Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Takao H, Minabe Y, Nakatani N, Higuchi T, Detera-Wadleigh SD, Yoshikawa T. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biological Psychiatry. 60: 192-201. PMID 16487942 DOI: 10.1016/j.biopsych.2005.11.008 |
0.546 |
|
| 2005 |
Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa M, Mori N, Iyo M, et al. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels. Biological Psychiatry. 57: 1493-503. PMID 15953485 DOI: 10.1016/j.biopsych.2005.03.018 |
0.535 |
|
| 2005 |
Yoshikawa T, Ohnishi T. [Molecular genetic approach to depression from animal models]. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 125: 25-32. PMID 15738618 DOI: 10.1254/fpj.125.25 |
0.409 |
|
| Show low-probability matches. |